AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 36094783
Drug: Third-dose combination
RxNorm normalized name: Third-generation cephalosporins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-dose combination of amlodipine, telmisartan, and chlorthalidone
Trial: 33155348
Drug: Culturally Adapted
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally Adapted Cognitive Behavioral Therapy Plus Problem Management (CA-CBT+)
Trial: 35794487
Drug: Peloid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peloid therapy and home exercise
Trial: 35794487
Drug: Paraffin therapy
RxNorm normalized name: Paraffin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paraffin therapy and home exercise
Trial: 33355078
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid administration at the beginning of RARP
Trial: 35631257
Drug: Ferric sodium
RxNorm normalized name: Ferric sodium EDTA
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferric sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate, and selenomethionine (Group 2; N = 22)
Trial: 35631257
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulfate (Group 1; N = 20)
Trial: 35631257
Drug: Ferric liposomal
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferric liposomal formulation (Group 3; N = 20)
Trial: 35630079
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (continued target medical therapy only)
Trial: 32089822
Drug: MVA-NP+M1 co-administered
RxNorm normalized name: Ceramide Np
DrugBank: Ceramide NP (DB14111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA-NP+M1 co-administered with licensed inactivated quadrivalent influenza vaccine
Trial: 33292022
Drug: PCSO‐524® (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCSO‐524® (600 mg/d)
Trial: 33292022
Drug: ESPO‐572® (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESPO‐572® (600 mg/d)
Trial: 35049070
Drug: Single-dose rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Single-dose rituximab (S-Rtx) 375 mg/m2
Trial: 35049070
Drug: Low-dose rituximab
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rituximab (LD-Rtx) 100 mg weekly for 4 weeks
Trial: 35258579
Drug: Pulsed low-intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed low-intensity ultrasonography (PLIUS) for 48 weeks, self-administered for 20 minutes daily.
Trial: 35258579
Drug: Sham ultrasonography
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham ultrasonography for 48 weeks, self-administered for 20 minutes daily.
Trial: 32209068
Drug: Sham ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham ultrasound therapy for 2 minutes
Trial: 35049249
Drug: Curcuma longa
RxNorm normalized name: Curcuma Longa
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuma longa (curcumin) 200 mg
Trial: 35049249
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (MA) 500 mg
Trial: 32285710
Drug: Energy drink
RxNorm normalized name: Boost Energy Drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy drink (250 mL Red Bull)
Trial: 33879118
Drug: 2-weekly mobile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-weekly mobile phone calls
Trial: 32900671
Drug: Internet-administered Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-administered Cognitive Behavioral Therapy (ICBT) for 12 weeks
Trial: 33789728
Drug: Fluralaner (Exzolt®;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluralaner (Exzolt®; 0.5 mg/kg body weight) administered twice, 7 days apart via drinking water.
Trial: 33789728
Drug: Fluralaner treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluralaner treatment
Trial: 33259933
Drug: Radical hemithoracic
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radical hemithoracic radiation therapy (RHR)
Trial: 33259933
Drug: Palliative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Palliative radiation therapy (PR)
Trial: 32851572
Drug: Other anticoagulant
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other anticoagulant treatments
Trial: 32198301
Drug: Method of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Method of administration (intravascular vs intracerebral)
Trial: 35124654
Drug: Bryostatin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bryostatin treatment
Trial: 32406431
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Vitamin A (2000 IU d‐1) and D (400 IU d‐1)
Trial: 32406431
Drug: Standard pulmonary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pulmonary tuberculosis therapy alone
Trial: 35944371
Drug: dTMS twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dTMS twice a day during 2 weeks
Trial: 35944371
Drug: dTMS twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dTMS twice a day during 3 weeks
Trial: 32725073
Drug: Liberal fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal fluid therapy (1500 ml of lactated Ringer's)
Trial: 32725073
Drug: Restrictive fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive fluid therapy (250 ml of lactated Ringer's)
Trial: 35440333
Drug: Evening primrose
RxNorm normalized name: EVENING PRIMROSE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening primrose vaginal capsule (500 mg) used vaginally, with a second capsule administered two hours later.
Trial: 34600602
Drug: Apalutamide 240
RxNorm normalized name: apalutamide 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apalutamide 240 mg once daily plus abiraterone acetate 1000 mg once daily and prednisone 5 mg twice daily
Trial: 34791068
Drug: Fluorine‐18 fluorodeoxyglucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluorine‐18 fluorodeoxyglucose (18F‐FDG) PET-CT scanning (FDG‐PET) before tapering (baseline) and after maximal tapering.
Trial: 32601973
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg NAC twice daily (high dose group)
Trial: 32601973
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg NAC daily (low dose group)
Trial: 32601973
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg NAC twice daily (high dose group) and 1200 mg NAC daily (low dose group)
Trial: 33830898
Drug: Micro-fragmented adipose
RxNorm normalized name: human adipose preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro-fragmented adipose tissue (MFAT) injections under ultrasound guidance
Trial: 32818641
Drug: Bleaching gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleaching gel activated with 915 nm diode laser (1.5 W)
Trial: 32818641
Drug: Bleaching gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleaching gel activated with 915 nm diode laser (2.5 W)
Trial: 32818641
Drug: Bleaching gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleaching gel activated with 445 nm diode laser (1 W)
Trial: 32818641
Drug: Bleaching gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleaching gel activated with 445 nm diode laser (1.5 W)
Trial: 32818641
Drug: Bleaching gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleaching gel without laser activation (control group)
Trial: 38856224
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg tirzepatide
Trial: 38856224
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg tirzepatide
Trial: 38856224
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg tirzepatide
Trial: 35778473
Drug: Antibody-immobilized ELISAs
RxNorm normalized name: digoxin antibodies Fab fragments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibody-immobilized ELISAs
Trial: 34503985
Drug: Navafenterol 600
RxNorm normalized name: Navafenterol
DrugBank: Navafenterol (DB19195)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Navafenterol 600 µg via inhalation
Trial: 34503985
Drug: Umeclidinium/vilanterol (UMEC/VI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umeclidinium/vilanterol (UMEC/VI) 62.5 µg/25 µg
Trial: 32977348
Drug: Pharmacotherapy (placebo-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy (placebo-controlled trial)
Trial: 32977348
Drug: Routine airway
RxNorm normalized name: inBreath airway transplant system
DrugBank: inBreath airway transplant system (DB18692)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine airway clearance and treatment of recurrent respiratory tract infections
Trial: 32977348
Drug: Organ-specific treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organ-specific treatment for non-respiratory symptoms
Trial: 32127889
Drug: Intra-operative low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-operative low-dose ketamine (0.15mg/kg bolus at induction and continuous infusion of 0.12 mg/kg/hour till start of skin closure)
Trial: 32127889
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received Morphine 0.1 mg/kg IV at debulking
Trial: 33315503
Drug: Fat graft
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat graft injections
Trial: 33315503
Drug: Nanofat-enriched fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nanofat-enriched fat graft injections
Trial: 32447857
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus hyperbaric oxygen (HBO) therapy
Trial: 32447857
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (simple HBO therapy)
Trial: 36056784
Drug: Intralesional purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional purified protein derivative (PPD) injected at a dose of 0.1 ml every 2 weeks until complete improvement or for a maximum of four sessions.
Trial: 36056784
Drug: Intralesional Candida
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional Candida antigen (CA) injected at a dose of 0.1 ml every 2 weeks until complete improvement or for a maximum of four sessions.
Trial: 36155998
Drug: Radiofrequency ozone
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency ozone therapy
Trial: 36155998
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of anti‐inflammatory analgesic solution into the internal orifice of nerve root
Trial: 36155998
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine hook operation (in addition to basic group treatment)
Trial: 34036813
Drug: Electroacupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture plus auricular acupressure treatment twice weekly for 6 weeks
Trial: 34036813
Drug: Electroacupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture plus auricular acupressure treatment
Trial: 33175623
Drug: Nanocolloidal silver-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nanocolloidal silver-based gel (SilvoGel)
Trial: 35587267
Drug: Selegiline (commercial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (commercial inhibitor of MAO-B)
Trial: 34247040
Drug: Wine group
RxNorm normalized name: Wine grape
DrugBank: Wine grape (DB10634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wine group (27 g of alcohol per day)
Trial: 34247040
Drug: Ethanol group
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol group (27 g of alcohol per day)
Trial: 34997314
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo + oral cetirizine 10 mg
Trial: 34997314
Drug: Intravenous diphenhydramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diphenhydramine 50 mg + oral placebo
Trial: 34318757
Drug: Standard-dose CT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose CT (120 kV and 300 mA)
Trial: 34318757
Drug: Low-dose CT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CT (80 kV and 40 mA)
Trial: 32170307
Drug: CBT-I concurrent
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT-I concurrent with PAP
Trial: 38578537
Drug: Bevacizumab-containing chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab-containing chemotherapy
Trial: 32283195
Drug: Oleogel-dissolved CoQ10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oleogel-dissolved CoQ10 (1 g CoQ10/5 g oleogel-disk)
Trial: 32283195
Drug: Oleogel-dissolved CoQ10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oleogel-dissolved CoQ10 (repeated-dose for 14 days)
Trial: 36346322
Drug: Spectrum Red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spectrum Red (2.5 mg THC, 0.3 mg CBD/softgel)
Trial: 36346322
Drug: Spectrum Yellow
RxNorm normalized name: yellow OB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spectrum Yellow (0.9 mg THC, 20 mg CBD/mL of oil)
Trial: 33572499
Drug: HIIT (High-Intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIIT (High-Intensity Interval Training) - 6 weeks, 12 bouts first 2 weeks, 16 bouts in weeks 3 and 4, and 20 bouts in the last two weeks x 30‐s intervals interspersed with 1‐min rest periods, performed thrice weekly
Trial: 32318695
Drug: Allopurinol 600
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 600 mg once daily for 20 weeks
Trial: 33248975
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg intravenous tranexamic acid
Trial: 33248975
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg intravenous tranexamic acid
Trial: 33248975
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg intravenous tranexamic acid
Trial: 35414602
Drug: Intensive glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive glucose treatment (serum glucose <110 mg/dL)
Trial: 35414602
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (serum glucose <180 mg/dL)
Trial: 32429680
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment (diclofenac sodium)
Trial: 32429680
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) and pharmacological treatment (diclofenac sodium)
Trial: 34358953
Drug: High g1
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High g1 treatment
Trial: 34358953
Drug: Standard g1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard g1 treatment
Trial: 33067280
Drug: Initiation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initiation of mental healthcare (psychometric testing by GP, talk therapy by GP, contact with a psychologist, contact with a psychiatrist, psychotropic medication)
Trial: 34206058
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B birth dose vaccine (HepB‐BD) administered to infants in addition to routine vaccines (0-8-12-16 weeks) during the intervention period.
Trial: 34142748
Drug: Transdiagnostic cognitive-behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdiagnostic cognitive-behavior therapy (tCBT)
Trial: 35981838
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline hydration (control)
Trial: 33030846
Drug: Yoga (performed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga (performed twice a week for ten sessions)
Trial: 35546299
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy (PBMT) with 915 nm diode laser (1.5 W, duty cycle of 60%, energy density of 72 J cm²)
Trial: 33437904
Drug: Machine learning
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Machine learning algorithm using a combination of IL-2, MIG/CCL9, RANTES/CCL5, SCF, and TRAIL
Trial: 32985237
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nutritional supplementation and resistance exercise
Trial: 34142184
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml of autologous micro-fragmented adipose tissue
Trial: 32319087
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg rocuronium iv
Trial: 32319087
Drug: 0.30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.30 mg/kg rocuronium iv
Trial: 32319087
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no additional drug administration)
Trial: 33681744
Drug: Intramuscular midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular midazolam (5 mg)
Trial: 35719707
Drug: Curcumin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (500 mg twice a day)
Trial: 35719707
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (500 mg twice a day)
Trial: 35719707
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mg microcrystalline cellulose twice a day)
Trial: 32520623
Drug: KBP-5074 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KBP-5074 0.25 mg
Trial: 32520623
Drug: KBP-5074 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KBP-5074 0.5 mg
Trial: 32520623
Drug: KBP-5074 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KBP-5074 (both doses)
Trial: 32197408
Drug: HD plus
RxNorm normalized name: Endal-HD Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD plus De Simone Formulation probiotic blend
Trial: 32022771
Drug: Aspirin in
RxNorm normalized name: Non-Aspirin Infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin in patients with previous percutaneous coronary intervention
Trial: 32022771
Drug: Control (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (placebo for both aspirin and clonidine)
Trial: 35081564
Drug: Combination pulsed-dye
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination pulsed-dye laser (PDL) and nonablative fractional laser (NAFL)
Trial: 34836240
Drug: L-carnitine tartrate
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-carnitine tartrate at 50 µM and creatine monohydrate at 0.5 µM combined
Trial: 34836240
Drug: Creatine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine with LMP formulation at 51 mg/kg
Trial: 34836240
Drug: LMP formulated
RxNorm normalized name: Tarsum Reformulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMP formulated L-carnitine at 500 mg with LMP formulated creatine at 100, 200, or 500 mg
Trial: 33291975
Drug: Meloxicam intravenous
RxNorm normalized name: Meloxicam
DrugBank: Meloxicam (DB00814)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meloxicam intravenous (30 mg once daily)
Trial: 33291975
Drug: Meloxicam intravenous
RxNorm normalized name: Meloxicam
DrugBank: Meloxicam (DB00814)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meloxicam intravenous
Trial: 33371107
Drug: Qiangji Jianli
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qiangji Jianli Capsule (QJC)
Trial: 33691519
Drug: Parent ratings
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent ratings of child functioning before treatment